AUPH FY 2009 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+4.5% YoY

Gross Profit

$3M85.8% margin

Operating Income

-$10M-247.9% margin

Net Income

-$8M-187.5% margin

EPS (Diluted)

$-3.17

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$11M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$10M

Total Liabilities

$5M

Stockholders' Equity

$5M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$4M	+4.5%
Gross Profit	$3M	$2M	+97.3%
Operating Income	-$10M	-$16M	+38.6%
Net Income	-$8M	-$16M	+52.2%